Serotonin Uptake InhibitorsAdrenergic Uptake InhibitorsFluoxetineCitalopramParoxetineAntidepressive AgentsPropylaminesAntidepressive Agents, TricyclicDesipramineFluvoxamineAntidepressive Agents, Second-GenerationCyclohexanolsSerotoninSertralineNorepinephrineSerotonin Plasma Membrane Transport ProteinsSerotonin SyndromeNeurotransmitter Uptake InhibitorsDepressive DisorderThiophenesNorepinephrine Plasma Membrane Transport ProteinsDepressive Disorder, MajorReceptor, Serotonin, 5-HT1AReceptors, SerotoninSerotonin AntagonistsReceptors, Serotonin, 5-HT1DepressionLofepramineRats, Sprague-DawleyDothiepinSerotonin Receptor AgonistsReceptor, Serotonin, 5-HT2AClomipramineSerotonin 5-HT1 Receptor AntagonistsObsessive-Compulsive Disorder1-NaphthylamineSerotonergic NeuronsPremenstrual SyndromeReceptor, Serotonin, 5-HT1B8-Hydroxy-2-(di-n-propylamino)tetralinSerotonin 5-HT2 Receptor AntagonistsRaphe NucleiAnti-Anxiety AgentsSerotonin AgentsDose-Response Relationship, DrugReceptors, Serotonin, 5-HT2Toxicity Tests, SubacuteBehavior, AnimalDrug InteractionsSerotonin 5-HT4 Receptor AgonistsFenfluramineMonoamine Oxidase InhibitorsDibenzothiepinsAnxiety DisordersSuicideTryptophan HydroxylaseMianserinDepressive Disorder, Treatment-ResistantTreatment OutcomePsychiatric Status Rating ScalesCognitive TherapySwimmingDouble-Blind MethodMicrodialysisPregnancy ComplicationsAnxietySexual Dysfunction, PhysiologicalSerotonin 5-HT1 Receptor AgonistsDroxidopaNortriptylineMoclobemidePiperazines5,7-DihydroxytryptamineAutoreceptorsAmitriptylinePanic DisorderReceptor, Serotonin, 5-HT2CAntipsychotic Agents5-HydroxytryptophanMorpholinesImipraminePatient DropoutsPsychotropic DrugsRandomized Controlled Trials as TopicBrainPsychotherapyImmobility Response, TonicCytochrome P-450 CYP2D6AlprazolamPhenelzineAnalysis of VarianceDrug Utilization ReviewBupropionMotor ActivityHindlimb SuspensionTime FactorsPlacebosMembrane Transport ProteinsEjaculationMaprotiline